James Cheng‐Chung Wei
- Rheumatology top 0.1%
- Spondyloarthritis Studies and Treatments 102
- Rheumatoid Arthritis Research and Therapies 91
- Systemic Lupus Erythematosus Research 50
- Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research 39
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis 57
- Catalysis top 2%
- Inorganic Chemistry top 1%
-
- Diabetes Treatment and Management 30
-
- Gout, Hyperuricemia, Uric Acid 24
-
- Dermatology and Skin Diseases 22
- Co-authors
- Nan YaoVincenzo LordiShiow‐Ing WangYu‐Hsun WangFu‐Shun YenJoachim SieperJing‐Yang HuangYao‐Min Hung
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
James Cheng‐Chung Wei
549 papers receiving 12.0k citations
Hit Papers
Peers
Comparison fields: 5 of 210
- Rheumatology 3.9k
- Hematology 1.5k
- Immunology 2.5k
- Catalysis 514
- Inorganic Chemistry 886
Countries citing papers authored by James Cheng‐Chung Wei
This map shows the geographic impact of James Cheng‐Chung Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Cheng‐Chung Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Cheng‐Chung Wei more than expected).
Fields of papers citing papers by James Cheng‐Chung Wei
This network shows the impact of papers produced by James Cheng‐Chung Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Cheng‐Chung Wei. The network helps show where James Cheng‐Chung Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Cheng‐Chung Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 14 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 2 | |
| 10 | 2023 | 3 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 2 | |
| 13 | 2023 | 5 | |
| 14 | 2023 | 1 | |
| 15 | 2022 | 3 | |
| 16 | 2021 | 3 | |
| 17 | 2020 | 10 | |
| 18 | 2018 | 8 | |
| 19 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging studybreakdown → | 2017 | 272 |
| 20 | 1964 | 250 |
About James Cheng‐Chung Wei
James Cheng‐Chung Wei is a scholar working on Rheumatology, Immunology and Hematology, having authored 581 papers that have together received 12.4k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (102 papers), Rheumatoid Arthritis Research and Therapies (91 papers), Psoriasis: Treatment and Pathogenesis (57 papers), Systemic Lupus Erythematosus Research (50 papers), Autoimmune and Inflammatory Disorders Research (39 papers), Diabetes Treatment and Management (30 papers), Gout, Hyperuricemia, Uric Acid (24 papers) and Dermatology and Skin Diseases (22 papers). The work is most often cited by research in Rheumatology (3.9k citations), Hematology (1.5k citations) and Immunology (2.5k citations). James Cheng‐Chung Wei has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Nan Yao, Vincenzo Lordi, Shiow‐Ing Wang, Yu‐Hsun Wang, Fu‐Shun Yen, Joachim Sieper, Jing‐Yang Huang, Yao‐Min Hung, Chii‐Min Hwu and Jeng‐Yuan Chiou.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.